Radioimmunoimaging and radioimmunotherapy applications are supported by the MILabs VECTorCT platform at the University of Saskatchewan, including:
‣ Daratumumab-225Actinium Conjugate Demonstrates Greatly Enhanced Antitumor Activity Against Experimental Multiple Myeloma Tumors
‣ Comparative Radioimmunotherapy of Experimental Melanoma With Novel Humanized Antibody to Melanin Labeled With 213Bismuth and 177Lutetium
